Vaxart VXRT
OTC VXRT
$0.48 -0.01 (-2.04%)
At close: Oct 21, 2026 · 4:00 PM EDT

Vaxart (VXRT) Amortization of Deferred Charges (2017 - 2018)

Updated

Analysis

Vaxart (VXRT) Amortization of Deferred Charges (2017 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Vaxart 106.67 Mn 42.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 18,000.00
Mar 31, 2017 36,000.00
API Access

Vaxart Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=VXRT&period=max&api_key=YOUR_API_KEY